Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
CA 2390646 A1 · Owner: Mitokor · Inventors: Anderson, Christen M.; Clevenger, William
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compositions and methods for altering mitochondrial ATP production, including binding and functional assays exploiting IF1 interactions with ATP synthase. Also disclosed are methods for screening assays for a compound capable of reducing mitochondrial ATP hydrolysis and/or increasing mitochondrial ATP synthesis including , pharmaceutical compositions identified by such methods. The invention also provides methods for treating diabetes and in particular, type 2 DM, using an agent identified according to the disclosed methods.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 10, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.